Project Grant HT94252510815
Award Date 9/30/25
Completion Date 9/29/28
Dollars Obligated $622K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Lake Mills, WI 53551, USA
Similar Awards
- This $700,000 Project Grant, awarded on August 15, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by Vanderbilt University Medical Center (VUMC) to target the DPEP1-neutrophil axis in microsatellite stable colorectal cancer. The funding will enable VUMC, a prominent academic medical center, to advance biomedical research focused on developing innovative medical solutions to address critical health...
- This Project Grant award for $5,099,737.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel therapeutic targeting myeloid cells for the treatment of glomerular diseases. The award was made to 149 Bio LLC in Miami, FL and has a period of performance from July 1, 2025 to June 30, 2029. The grant aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
- This $777,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting at the University of Wisconsin-Madison. The project aims to transform healthcare for military service members, veterans, and the broader public through advanced biomedical research. The 3-year project, commencing on June 1, 2025, will leverage the university's...
- This $729,778 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System supports a multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. The research, which will take place at the University of Wisconsin-Madison between June 1, 2025 and May 31, 2028, aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative...
- The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
- The Defense Health Agency awarded a $159,892 Project Grant to the University of Illinois under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant supports research into "Metabolic Vulnerabilities Associated to G12C Inhibitor Resistance" from January 1, 2022 through December 31, 2023. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award will...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- The Defense Health Agency awarded a $1,036,233 Project Grant to the Fred Hutchinson Cancer Research Center under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 2021 through June 2024 to develop more precise molecular classification and targeted treatment of metastatic castration-resistant prostate cancer (MCRPC) through multi-omic analysis of circulating tumor DNA (ctDNA). By leveraging ctDNA analysis, the research aims to transform...
- The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
- The Defense Health Agency awarded a $524,664 Project Grant to the Dana-Farber Cancer Institute, Inc. (DFCI) through the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, which runs from December 1, 2024 to November 30, 2026, will fund research into the "Mechanisms of Irisin-Induced Cognitive Benefit in PD." DFCI, a prestigious non-profit cancer research center in Boston, will leverage its expertise in areas like oncology, immunology, and...